Segmentation by types of DUWL solutions classifies the market into four principal product families: antimicrobial devices, filtration systems, chemical dosing units, and monitoring & control modules. Antimicrobial devices, employing silver‑ion or copper‑based technologies, capture the largest revenue share due to their direct impact on biofilm suppression and regulatory compliance. Filtration systems, including point‑of‑use membrane and carbon filters, serve as a complementary line, valued for their ability to remove particulates and reduce microbial load. Chemical dosing units, which dispense disinfectants such as chlorine dioxide or hydrogen peroxide, are adopted primarily in high‑throughput settings where continuous dosing is essential. Monitoring & control modules, encompassing sensors and software platforms, are gaining traction as digital integration becomes a strategic priority for clinics seeking real‑time compliance reporting. Collectively, these types shape the market’s value chain, with antimicrobial devices (~40 %), filtration systems (~30 %), chemical dosing units (~20 %), and monitoring modules (~10 %) reflecting current investment patterns across the DUWL landscape.